Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
about
Animal models of Middle East respiratory syndrome coronavirus infectionEpitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinCharacterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseToward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.The prevalence, origin, and prevention of six human coronaviruses.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.
P2860
Q28086778-577FA214-A286-4242-801C-D46FE2DB8E82Q30382230-B8758FA8-7537-437C-AA48-1FAF2AD86E2FQ30399700-23E72959-4E58-41A5-AB38-434CDD02CFA6Q30400066-A8EC7870-F811-43D9-BFD0-AB84E9A89CB9Q30402347-B4CFB6E4-E94B-43BC-B6E4-0E3CD5070CEAQ36433987-5144BBED-1B3A-464C-B999-9C8832FA2A35Q37169882-FAA92AE6-5A7C-4D50-9F86-E48A92419876Q37512915-7BF4FA0C-C6AE-4B91-ABAA-774A1AF018FDQ37717377-0A7B30D7-F7F9-41A7-A7E7-8DB9620A2383Q38778044-A9DB3B2E-FEBF-4250-847D-6957D5C6119EQ38959242-B0903A5D-052F-4FF8-A6FD-38E11F4B0AC0Q39102732-A18809FA-ADA5-489B-9670-A48F5ABA2EB6Q39184006-1A1A7A7B-2DE5-4445-91FE-D64E8308067FQ47607374-7FFCEB43-4C16-441A-A86D-A2167AC597A9Q53701486-84D76D2C-8287-430B-BB91-53C57D0BD91FQ55344910-F2910FFB-CB37-46ED-A63D-51D2820AF58A
P2860
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Optimization of antigen dose f ...... cine against MERS coronavirus.
@ast
Optimization of antigen dose f ...... cine against MERS coronavirus.
@en
type
label
Optimization of antigen dose f ...... cine against MERS coronavirus.
@ast
Optimization of antigen dose f ...... cine against MERS coronavirus.
@en
prefLabel
Optimization of antigen dose f ...... cine against MERS coronavirus.
@ast
Optimization of antigen dose f ...... cine against MERS coronavirus.
@en
P2093
P2860
P1476
Optimization of antigen dose f ...... cine against MERS coronavirus.
@en
P2093
Chien-Te K Tseng
Guangyu Zhao
Naru Zhang
Xinrong Tao
Yusen Zhou
P2860
P304
P356
10.1080/21645515.2015.1021527
P577
2015-01-01T00:00:00Z